10x Genomics (TXG) Cash & Equivalents Growth (3y) (2021 - 2026)

10x Genomics (TXG) Cash & Equivalents Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 20.14%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn -
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 5.55%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn -
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 13.84%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 11.52%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn -
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 10.47%
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn -19.91%
10 Teladoc Health 1.45 Bn 696.57 Mn 562.57 Mn -5.46%

Historic Data

Download Data
DateValue
Mar 31, 2026 13.84%
Dec 31, 2025 29.20%
Sep 30, 2025 22.73%
Jun 30, 2025 13.20%
Mar 31, 2025 6.46%
Dec 31, 2024 -16.33%
Sep 30, 2024 -12.80%
Jun 30, 2024 -15.16%
Mar 31, 2024 -16.78%
Dec 31, 2023 -18.50%
Sep 30, 2023 -26.02%
Jun 30, 2023 -1.39%
Mar 31, 2023 -3.73%
Dec 31, 2022 -19.69%
Sep 30, 2022 -18.20%
Dec 31, 2021 108.21%